Otsuka Pharmaceutical Co., Ltd. (Second Tokushima Factory) - B0808
Tesis Brezilya sağlık düzenleme kurumu (ANVISA) tarafından onaylanmıştır
Brezilya sağlık düzenleme kurumu ANVISA, bu tesis için aktif farmasötik içerikleri kapsayan ve 2028-05-13 tarihine kadar geçerli olan geçerli bir İyi Üretim Uygulaması sertifikasına sahiptir. Sertifika, tesisin kendi incelemesinden sonra veriliyor, bu nedenle yabancı bir düzenleyici bu siteyi adlandırıyor: Burada üretilen malların Brezilya pazarında bulunmasına izin veriliyor. İşlem numarası 25351772490202395.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Japan
- Categories
- İlaç Üretimi
- Markets
- Japonya, Brezilya
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- debarment-clear (green), checked 2026-09-02 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-09-02 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)